# EDGAR Filing Document

**Accession Number:** 0001014473
**File Stem:** 0001014473-26-000020
**Filing Date:** 2026-4
**Character Count:** 85074
**Document Hash:** e85a003768a208d3e1e2dc581d243194
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001014473-26-000020.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0001014473-26-000020

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 60

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERISIGN INC/CA
- **CENTRAL INDEX KEY:** 0001014473
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 943221585
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-23593
- **FILM NUMBER:** 26889152

**BUSINESS ADDRESS:**
- **STREET 1:** 12061 BLUEMONT WAY
- **STREET 2:** ATTN: GENERAL COUNSEL
- **CITY:** RESTON
- **STATE:** VA
- **ZIP:** 20190
- **BUSINESS PHONE:** 7039483200

**MAIL ADDRESS:**
- **STREET 1:** 12061 BLUEMONT WAY
- **STREET 2:** ATTN: GENERAL COUNSEL
- **CITY:** RESTON
- **STATE:** VA
- **ZIP:** 20190

?xml version='1.0' encoding='ASCII'? vrsn-20260331

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

    

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

____________________

**FORM 10-Q** 

____________________

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2026

OR

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Commission File Number: 000-23593

**VERISIGN, INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **Delaware** | **94-3221585** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |
| **12061 Bluemont Way,** | **12061 Bluemont Way,** | |
| **Reston,** | **Virginia** | **20190** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (703) 948-3200** 

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, $0.001 par value per share | VRSN | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp; Yes ☒ &nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp; Yes ☒&nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp; Yes ☐&nbsp;&nbsp;&nbsp;&nbsp; No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

---

| | |
|:---|:---|
| **<u>Class</u>** | **<u>Shares Outstanding as of April 17, 2026</u>** |
| Common stock, $0.001 par value per share | 91.0 million |

---

    

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| | **<u>[PART I—FINANCIAL INFORMATION](#i8aa50e23264647138c7f66a501a45c42_10)</u>** | |
| <u>Item 1.</u> | <u>[Financial Statements](#i8aa50e23264647138c7f66a501a45c42_10)</u> | <u>[3](#i8aa50e23264647138c7f66a501a45c42_10)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025](#i8aa50e23264647138c7f66a501a45c42_13)</u> | <u>[3](#i8aa50e23264647138c7f66a501a45c42_13)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income for the Three](#i8aa50e23264647138c7f66a501a45c42_19)[Months Ended](#i8aa50e23264647138c7f66a501a45c42_19)[March 31](#i8aa50e23264647138c7f66a501a45c42_19)[, 202](#i8aa50e23264647138c7f66a501a45c42_19)[6](#i8aa50e23264647138c7f66a501a45c42_19)[and 202](#i8aa50e23264647138c7f66a501a45c42_19)[5](#i8aa50e23264647138c7f66a501a45c42_19)</u> | <u>[4](#i8aa50e23264647138c7f66a501a45c42_19)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Stockholders' Deficit for the Three Months Ended March 31, 2026 and 2025](#i8aa50e23264647138c7f66a501a45c42_22)</u> | <u>[5](#i8aa50e23264647138c7f66a501a45c42_22)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025](#i8aa50e23264647138c7f66a501a45c42_25)</u> | <u>[6](#i8aa50e23264647138c7f66a501a45c42_25)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Condensed Consolidated Financial Statements](#i8aa50e23264647138c7f66a501a45c42_28)</u> | <u>[7](#i8aa50e23264647138c7f66a501a45c42_28)</u> |
| <u>[Item 2.](#i8aa50e23264647138c7f66a501a45c42_64)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i8aa50e23264647138c7f66a501a45c42_64)</u> | <u>[13](#i8aa50e23264647138c7f66a501a45c42_64)</u> |
| <u>[Item 3.](#i8aa50e23264647138c7f66a501a45c42_76)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i8aa50e23264647138c7f66a501a45c42_76)</u> | <u>[18](#i8aa50e23264647138c7f66a501a45c42_76)</u> |
| <u>[Item 4.](#i8aa50e23264647138c7f66a501a45c42_79)</u> | <u>[Controls and Procedures](#i8aa50e23264647138c7f66a501a45c42_79)</u> | <u>[18](#i8aa50e23264647138c7f66a501a45c42_79)</u> |
|  | **<u>[PART II—OTHER INFORMATION](#i8aa50e23264647138c7f66a501a45c42_82)</u>** |  |
| <u>[Item 1.](#i8aa50e23264647138c7f66a501a45c42_85)</u> | <u>[Legal Proceedings](#i8aa50e23264647138c7f66a501a45c42_85)</u> | <u>[19](#i8aa50e23264647138c7f66a501a45c42_85)</u> |
| <u>[Item 1A.](#i8aa50e23264647138c7f66a501a45c42_88)</u> | <u>[Risk Factors](#i8aa50e23264647138c7f66a501a45c42_88)</u> | <u>[19](#i8aa50e23264647138c7f66a501a45c42_88)</u> |
| <u>[Item 2.](#i8aa50e23264647138c7f66a501a45c42_91)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i8aa50e23264647138c7f66a501a45c42_91)</u> | <u>[19](#i8aa50e23264647138c7f66a501a45c42_91)</u> |
| <u>[Item 5.](#i8aa50e23264647138c7f66a501a45c42_94)</u> | <u>[Other Information](#i8aa50e23264647138c7f66a501a45c42_94)</u> | <u>[20](#i8aa50e23264647138c7f66a501a45c42_94)</u> |
| <u>[Item 6.](#i8aa50e23264647138c7f66a501a45c42_97)</u> | <u>[Exhibits](#i8aa50e23264647138c7f66a501a45c42_97)</u> | <u>[20](#i8aa50e23264647138c7f66a501a45c42_97)</u> |
| <u>[Signatures](#i8aa50e23264647138c7f66a501a45c42_100)</u> | <u>[Signatures](#i8aa50e23264647138c7f66a501a45c42_100)</u> | <u>[21](#i8aa50e23264647138c7f66a501a45c42_100)</u> |

---

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**PART I—FINANCIAL INFORMATION**

**ITEM 1. &nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS**

**VERISIGN, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(In millions, except par value)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **<u>ASSETS</u>** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $476.7 | $307.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marketable securities | 79.7 | 272.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 69.6 | 72.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 626.0 | 652.5 |
| Property and equipment, net | 214.2 | 213.7 |
| Goodwill | 52.5 | 52.5 |
| Deferred tax assets | 227.9 | 233.2 |
| Deposits to acquire intangible assets | 145.2 | 145.2 |
| Other long-term assets | 31.4 | 28.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term assets | 671.2 | 673.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1297.2 | $1325.9 |
| **<u>LIABILITIES AND STOCKHOLDERS' DEFICIT</u>** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $283.9 | $298.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenues | 1071.2 | 1035.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 1355.1 | 1333.1 |
| Long-term deferred revenues | 358.2 | 349.4 |
| Long-term senior notes | 1788.8 | 1788.2 |
| Long-term tax and other liabilities | 8.5 | 9.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 2155.5 | 2147.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 3510.6 | 3480.1 |
| Commitments and contingencies |  |  |
| Stockholders' deficit: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock—par value $.001 per share; Authorized shares: 5.0; Issued and outstanding shares: none |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock and additional paid-in capital—par value $.001 per share; Authorized shares: 1,000; Issued shares: 355.8 at March 31, 2026 and 355.6 at December 31, 2025; Outstanding shares: 91.1 at March 31, 2026 and 91.9 at December 31, 2025 | 9349.9 | 9623.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (11560.5) | (11775.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (2.8) | (2.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' deficit | (2213.4) | (2154.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' deficit | $1297.2 | $1325.9 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**VERISIGN, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(In millions, except per share data)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Revenues | $428.9 | $402.3 |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues | 49.2 | 49.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 27.5 | 26.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 58.6 | 55.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total costs and expenses | 135.3 | 131.1 |
| Operating income | 293.6 | 271.2 |
| Interest expense | (18.9) | (20.3) |
| Non-operating income, net | 4.7 | 7.5 |
| Income before income taxes | 279.4 | 258.4 |
| Income tax expense | (64.9) | (59.1) |
| Net income | 214.5 | 199.3 |
| Other comprehensive loss | (0.1) | (0.3) |
| Comprehensive income | $214.4 | $199.0 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $2.34 | $2.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $2.34 | $2.10 |
| Shares used to compute earnings per share |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 91.6 | 94.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 91.8 | 94.8 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**VERISIGN, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT**

**(In millions)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Total stockholders' deficit, beginning of period | $(2154.2) | $(1957.9) |
| Common stock and additional paid-in capital |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning balance | 9623.5 | 10645.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | (225.4) | (241.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock cash dividends | (74.2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 19.3 | 17.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock under stock plans | 8.5 | 7.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excise tax on repurchase of common stock | (1.8) | (2.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | 9349.9 | 10427.2 |
| Accumulated deficit |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning balance | (11775.0) | (12600.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 214.5 | 199.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | (11560.5) | (12401.4) |
| Accumulated other comprehensive loss |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning balance | (2.7) | (2.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive loss | (0.1) | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | (2.8) | (2.8) |
| Total stockholders' deficit, end of period | $(2213.4) | $(1977.0) |
| Cash dividends declared per common share | $0.81 | $— |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**VERISIGN, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(In millions)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $214.5 | $199.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation of property and equipment | 6.4 | 8.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 19.1 | 17.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of discount on investments in debt securities | (1.6) | (3.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 0.4 | 1.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (0.4) | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | (16.2) | 6.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenues | 44.9 | 57.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net deferred income taxes | 5.3 | 4.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 272.4 | 291.3 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from maturities and sales of marketable securities | 273.8 | 358.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of marketable securities | (79.4) | (35.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (7.2) | (5.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by investing activities | 187.2 | 317.6 |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchases of common stock | (225.4) | (241.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of dividends | (74.2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from employee stock purchase plan | 8.5 | 7.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of borrowings |  | (500.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from senior note issuance, net of issuance costs |  | 493.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (291.1) | (239.9) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 0.3 | (0.3) |
| Net increase in cash, cash equivalents, and restricted cash | 168.8 | 368.7 |
| Cash, cash equivalents, and restricted cash at beginning of period | 309.5 | 212.1 |
| Cash, cash equivalents, and restricted cash at end of period | $478.3 | $580.8 |
| Supplemental cash flow disclosures: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $13.1 | $26.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes, net of refunds received | $28.7 | $20.0 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**VERISIGN, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**Note 1. Basis of Presentation**

*Interim Financial Statements*

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared by VeriSign, Inc. ("Verisign" or the "Company") in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, therefore, do not include all information and notes normally provided in audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included. The results of operations for any interim period are not necessarily indicative of, nor comparable to, the results of operations for any other interim period or for a full fiscal year. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and related notes contained in Verisign's Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K") filed with the SEC on February 5, 2026.

*Recent Accounting Pronouncements*

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2024-03, *Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires additional disclosure of certain costs and expenses within the notes to the financial statements. This guidance will be effective for the Company's 2027 Form 10-K. The Company does not expect the adoption of this guidance to have a material impact on the Company's consolidated financial statements.

In September 2025, the FASB issued ASU No. 2025-06, *Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software*, which clarifies and modernizes certain aspects of the accounting for and disclosure of internal-use software costs. The ASU does not change what types of costs are capitalized or when internal-use software cost capitalization ceases. This guidance will be effective for the Company in 2028. The Company does not expect the adoption of this guidance to have a material impact on the Company's consolidated financial statements.

**Note 2. Financial Instruments**

*Cash, Cash Equivalents, and Marketable Securities*

The following table summarizes the Company's cash, cash equivalents, and marketable securities and the fair value categorization of the financial instruments measured at fair value on a recurring basis:

---

| | | |
|:---|:---|:---|
| | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| | **(In millions)** | **(In millions)** |
| Cash | $16.8 | $18.5 |
| Time deposits | 2.2 | 1.9 |
| Money market funds (Level 1) | 169.7 | 243.3 |
| Debt securities issued by the U.S. Treasury (Level 1) | 369.3 | 318.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $558.0 | $582.1 |
| Cash and cash equivalents | $476.7 | $307.9 |
| Restricted cash (included in Other long-term assets) | 1.6 | 1.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Cash, cash equivalents, and restricted cash | 478.3 | 309.5 |
| Marketable securities | 79.7 | 272.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $558.0 | $582.1 |

---

The gross and net unrealized gains and losses included in the fair value of the debt securities were not significant for the periods presented. All of the debt securities held as of March 31, 2026 are scheduled to mature in less than one year.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

*Fair Value Measurements*

The fair value of the Company's investments in money market funds approximates their face value. Such instruments are included in Cash and cash equivalents. The fair value of the debt securities consisting of U.S. Treasury bills is based on their quoted market prices. Debt securities purchased with original maturities in excess of three months are included in Marketable securities. The fair value of the Company's foreign currency forward contracts is based on foreign currency rates quoted by banks or foreign currency dealers and other public data sources. The fair value of all of these financial instruments are classified as Level 1 in the fair value hierarchy.

As of March 31, 2026, the Company's other financial instruments include cash, accounts receivable, restricted cash, and accounts payable whose carrying values approximated their face values. The aggregate fair value of the Company's senior notes is $1.73 billion and $1.75 billion as of March 31, 2026 and December 31, 2025, respectively. The fair values of these debt instruments are based on available market information from public data sources and are classified as Level 2.

**Note 3. Selected Balance Sheet Items**

*Other Current Assets*

Other current assets consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| | **(In millions)** | **(In millions)** |
| Prepaid expenses | $29.5 | $28.1 |
| Prepaid registry fees | 27.4 | 26.6 |
| Accounts receivable, net | 11.3 | 7.7 |
| Taxes receivable | 0.6 | 7.2 |
| Other | 0.8 | 2.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other current assets | $69.6 | $72.0 |

---

*Property and Equipment, Net*

Certain assets included in property and equipment, net were classified as held for sale as of March 31, 2026 and December 31, 2025. These assets are not material.

*Other Long-Term Assets*

Other long-term assets consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| | **(In millions)** | **(In millions)** |
| Operating lease right-of-use asset | $9.6 | $9.8 |
| Long-term prepaid expenses | 9.4 | 6.5 |
| Long-term prepaid registry fees | 8.6 | 8.4 |
| Restricted cash | 1.6 | 1.6 |
| Other | 2.2 | 2.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other long-term assets | $31.4 | $28.8 |

---

The prepaid registry fees in the tables above primarily relate to the fees the Company pays to ICANN for each annual term of .*com* domain name registrations and renewals which are deferred and amortized over the domain name registration term.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

*Accounts Payable and Accrued Liabilities*

Accounts payable and accrued liabilities consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| | **(In millions)** | **(In millions)** |
| Accounts payable and accrued expenses | $10.5 | $13.8 |
| Taxes payable | 91.2 | 64.0 |
| Customer deposits | 81.0 | 92.6 |
| Accrued employee compensation | 42.8 | 77.2 |
| Interest payable | 20.2 | 15.1 |
| Accrued registry fees | 14.7 | 13.4 |
| Customer incentives payable | 14.3 | 13.2 |
| Current operating lease liabilities | 5.8 | 5.8 |
| Other accrued liabilities | 3.4 | 2.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total accounts payable and accrued liabilities | $283.9 | $298.0 |

---

Taxes payable reflects amounts accrued for the income tax provision net of payments made during the period. This balance fluctuates from period to period due to the timing of income tax payments in the Company's major tax jurisdictions. Customer deposits vary from period to period due to the timing of payments from certain large customers. Accrued employee compensation primarily consists of liabilities for employee leave, salaries, payroll taxes, employee contributions to the employee stock purchase plan, and incentive compensation. Accrued employee incentive compensation as of December 31, 2025 was paid during the three months ended March 31, 2026.

**Note 4. Stockholders' Deficit**

Effective July 24, 2025, the Company's Board of Directors authorized the repurchase of its common stock in the amount of $913.1 million, in addition to the $586.9 million that remained available for repurchases under the prior share repurchase authorization, for a total repurchase authorization of up to $1.50 billion under the program. The program has no expiration date. Purchases made under the program can be effected through open market transactions, block purchases, accelerated share repurchase agreements or other negotiated transactions. As of March 31, 2026 there was $862.8 million remaining available for repurchases under the program.

A summary of the Company's common stock repurchases is as follows. Amounts may not add up due to rounding:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| | **Shares** | **Total Costs** | **Average Price** |
| | **(In millions, except average price amounts)** | **(In millions, except average price amounts)** | **(In millions, except average price amounts)** |
| Total repurchases under the repurchase plans | 0.9 | $214.4 | $234.88 |
| Total repurchases for tax withholdings |  | 11.1 | $228.39 |
| Total repurchases | 1.0 | $225.4 | $234.55 |

---

Since inception, the Company has repurchased 264.7 million shares of its common stock for an aggregate cost of $15.99 billion, which is recorded as a reduction of Additional paid-in capital. The share repurchase and authorization amounts disclosed within this Form 10-Q exclude the excise tax on share repurchases.

On February 3, 2026, the Company's Board of Directors declared a cash dividend of $0.81 per share of the Company's outstanding common stock, totaling $74.2 million, which was paid on February 27, 2026. The dividend was accounted for as a reduction of Additional paid-in capital. On April 20, 2026, the Company's Board of Directors declared a cash dividend of $0.81 per share of the Company's outstanding common stock to stockholders of record as of the close of business on May 19, 2026, payable on May 27, 2026. The Company intends to continue to pay a cash dividend on a quarterly basis, subject to market conditions and approval by the Company's Board of Directors.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**Note 5. Calculation of Earnings per Share** 

The following table presents the computation of weighted-average shares used in the calculation of basic and diluted earnings per share:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(In millions)** | **(In millions)** |
| Weighted-average shares of common stock outstanding | 91.6 | 94.6 |
| Weighted-average potential shares of common stock outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unvested RSUs and ESPP | 0.2 | 0.2 |
| Shares used to compute diluted earnings per share | 91.8 | 94.8 |

---

The calculation of diluted weighted average shares outstanding excludes performance-based RSUs granted by the Company for which the relevant performance criteria have not been achieved and any awards that are antidilutive. The number of potential shares excluded from the calculation was not significant in any period presented.

**Note 6. Segment Information**

The Company has one reportable segment that includes all the operations of the business. The chief operating decision maker assesses performance and decides how to allocate resources based on revenues, operating income and net income as reported on the Consolidated Statements of Comprehensive Income.

The following table presents information about segment revenues, significant expenses and profits:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(In millions)** | **(In millions)** |
| Revenues | $428.9 | $402.3 |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits expenses | 64.9 | 62.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expenses | 19.1 | 17.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equipment and software expenses | 13.8 | 12.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registry fee expenses | 11.6 | 11.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation expenses | 6.4 | 8.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other segment items | 19.5 | 19.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total costs and expenses | 135.3 | 131.1 |
| Operating income | 293.6 | 271.2 |
| Interest expense | (18.9) | (20.3) |
| Non-operating income, net | 4.7 | 7.5 |
| Income tax expense | (64.9) | (59.1) |
| Net income | $214.5 | $199.3 |

---

Other segment items that are a part of the Company's segment net income include professional services expenses, telecommunication expenses, legal expenses, and occupancy expenses.

**Note 7. Revenues** 

The Company generates revenues in the U.S.; Europe, the Middle East and Africa ("EMEA"); Australia, China, Japan, Singapore, and other Asia Pacific countries ("APAC"); and certain other countries, including Canada and Latin American countries.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

The following table presents the Company's revenues disaggregated by geography, based on the billing addresses of the Company's customers:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(In millions)** | **(In millions)** |
| U.S. | $283.4 | $266.1 |
| EMEA | 73.5 | 67.0 |
| APAC | 48.0 | 44.4 |
| Other | 24.0 | 24.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $428.9 | $402.3 |

---

Revenues in the table above are attributed to the country of domicile and the respective regions in which registrars are located; however, this may differ from the regions where the registrars operate or where registrants are located. Revenues for each region may be impacted by registrars reincorporating, relocating, or from acquisitions or changes in affiliations of resellers. Revenues for each region may also be impacted by registrars domiciled in one region, registering domain names in another region.

*Deferred Revenues*

As payment for domain name registrations and renewals are due in advance of the Company's performance, the Company records these amounts as deferred revenues. The increase in the deferred revenues balance for the three months ended March 31, 2026 was primarily driven by amounts billed in the three months ended March 31, 2026 for domain name registrations and renewals to be recognized as revenues in future periods, offset by refunds for domain name renewals deleted during the 45-day grace period, and $384.1 million of revenues recognized that were included in the deferred revenues balance at December 31, 2025. The balance of deferred revenues as of March 31, 2026 represents the Company's aggregate remaining performance obligations. Amounts included in current deferred revenues are all expected to be recognized in revenues within 12 months, except for a portion of deferred revenues that relates to domain name renewals that are deleted in the 45-day grace period following the transaction. The long-term deferred revenues amounts will be recognized in revenues over several years, and in some cases, up to ten years.

**Note 8. Stock-based Compensation**

Stock-based compensation is classified in the Condensed Consolidated Statements of Comprehensive Income in the same expense line items as cash compensation. The following table presents the classification of stock-based compensation:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(In millions)** | **(In millions)** |
| Cost of revenues | $2.3 | $2.1 |
| Research and development | 3.0 | 2.8 |
| Selling, general and administrative | 13.8 | 12.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 19.1 | 17.5 |
| Capitalization (included in Property and equipment, net) | 0.2 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stock-based compensation | $19.3 | $17.7 |

---

The following table presents the nature of the Company's total stock-based compensation:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(In millions)** | **(In millions)** |
| RSUs | $13.4 | $13 |
| Performance-based RSUs | 4.9 | 3.8 |
| ESPP | 1.0 | 0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stock-based compensation | $19.3 | $17.7 |

---

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**Note 9. Non-operating Income, Net**

Non-operating income, net, primarily consists of interest income from the Company's surplus cash balances and marketable securities. Interest income was $5.2 million and $7.9 million during the three months ended March 31, 2026 and 2025, respectively. The decrease in interest income during the three months ended March 31, 2026 primarily reflects the lower amounts invested in debt securities in the current period and lower interest rates on the Company's investments in debt securities compared to the prior period.

**Note 10. Income Taxes**

The following table presents income tax expense and the effective tax rate:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Income tax expense | $64.9 | $59.1 |
| Effective tax rate | 23% | 23% |

---

The effective tax rate for each of the periods in the table above differed from the statutory federal rate of 21%, due to state income taxes and U.S. taxes on foreign earnings, net of foreign tax credits, partially offset by a lower foreign effective tax rate.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*You should read the following discussion in conjunction with the 2025 Form 10-K and the interim unaudited Condensed Consolidated Financial Statements and related notes included in Part I, Item I of this Quarterly Report on Form 10-Q.*

*This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements are based on current expectations and assumptions and involve risks, uncertainties, and other important factors, including, among other things, statements regarding the Company's quarterly dividend and our expectations about the sufficiency of our existing cash, cash equivalents and marketable securities, and funds generated from operations, together with our borrowing capacity under the unsecured revolving credit facility. In some cases, you can identify forward-looking statements by terms such as "assumes," "could," "estimates," "forecasts," "may," "plans," "potential," "predicts," "projects," "should," "targets," "will," "would," "seeks," "expects," "anticipates," "intends," "believes" and similar language intended to identify forward-looking statements. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in the section titled "Risk Factors" in Part I, Item 1A of the 2025 Form 10-K. You should also carefully review the risks described in other documents we file from time to time with the Securities and Exchange Commission, including the Quarterly Reports on Form 10-Q or Current Reports on Form 8-K that we file in 2026. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. We undertake no obligation to update publicly or revise such statements, whether as a result of new information, future events, or otherwise, except as required by law.*

*For purposes of this Quarterly Report on Form 10-Q, the terms "Verisign," "the Company," "we," "us," and "our" refer to VeriSign, Inc. and its consolidated subsidiaries.*

**Overview**

We are a global provider of critical internet infrastructure and domain name registry services, enabling internet navigation for many of the world's most recognized domain names. We help enable the security, stability, and resiliency of the Domain Name System and the internet by providing Root Zone Maintainer Services, operating two of the thirteen global internet root servers, and providing registration services and authoritative resolution for the .*com* and .*net* generic top-level domains ("gTLDs"), which support the majority of global e-commerce.

As of March 31, 2026, we had 176.1 million *.com* and *.net* registrations in the domain name base. The number of domain names registered is largely driven by continued growth in online advertising, e-commerce, and the number of internet users, which is partially driven by greater availability of internet access, as well as marketing activities carried out by us and our registrars. The number of domain name registrations under our management may be negatively impacted by certain factors, including overall economic conditions, competition from country code top-level domains ("ccTLDs"), other gTLDs, services that offer alternatives for an online presence, and ongoing changes in the internet practices and behaviors of consumers and businesses. Factors such as the evolving practices and preferences of internet users, and how they navigate the internet, as well as the motivation of domain name registrants and how they will manage their investment in domain names, can negatively impact our business and the demand for new domain name registrations and renewals.

***Business Highlights and Trends***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We recorded revenues of $428.9 million during the three months ended March 31, 2026, which represents an increase of 7% compared to the same period in 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We recorded operating income of $293.6 million during the three months ended March 31, 2026, which represents an increase of 8% compared to the same period in 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• As of March 31, 2026, we had 176.1 million *.com* and *.net* registrations in the domain name base, which represents a 3.7% increase from March 31, 2025, and a net increase of 2.5 million domain name registrations from December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• During the three months ended March 31, 2026, we processed 11.5 million new domain name registrations for *.com* and *.net* compared to 10.1 million for the same period in 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The final .*com* and .*net* renewal rate for the fourth quarter of 2025 was 75.0% compared to 74.0% for the fourth quarter of 2024. Renewal rates are not fully measurable until 45 days after the end of the quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We generated cash flows from operating activities of $272.4 million during the three months ended March 31, 2026, compared to $291.3 million for the same period in 2025.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** During the three months ended March 31, 2026, we repurchased 0.9 million shares of common stock for an aggregate cost of $214.4 million. As of March 31, 2026, there was $862.8 million remaining for future share repurchases under the share repurchase program.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On April 20, 2026, the Board of Directors declared a cash dividend of $0.81 per share of the Company's outstanding common stock to stockholders of record as of the close of business on May 19, 2026, payable on May 27, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On April 23, 2026, we announced that we will increase the annual registry-level wholesale fee for each new and renewal .*com* domain name registration from $10.26 to $10.97 effective November 1, 2026.

Pursuant to our agreements with ICANN, we make available files containing all active domain names registered in the *.com* and *.net* registries. Further, we also make available a summary of the active zone count registered in the *.com* and *.net* registries and the number of *.com* and *.net* domain name registrations in the domain name base. The zone counts and information on how to obtain access to the zone files can be found at <u>https://www.verisign.com/resources/zone-file</u>. The domain name base is the active zone plus the number of domain names that are registered but not configured for use in the respective top-level domain zone file plus the number of domain names that are in a client or server hold status. The domain name base may also reflect compensated or uncompensated judicial or administrative actions to add or remove from the active zone an immaterial number of domain names. These files and the related summary data are updated daily. The update times may vary each day. The number of domain names provided in this Form 10-Q are as of midnight of the date reported.

**Results of Operations**

The following table presents information regarding our results of operations as a percentage of revenues:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Revenues | 100.0% | 100.0% |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues | 11.5 | 12.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 6.4 | 6.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 13.6 | 13.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total costs and expenses | 31.5 | 32.6 |
| Operating income | 68.5 | 67.4 |
| Interest expense | (4.4) | (5.0) |
| Non-operating income, net | 1.0 | 1.8 |
| Income before income taxes | 65.1 | 64.2 |
| Income tax expense | (15.1) | (14.7) |
| Net income | 50.0% | 49.5% |

---

***Revenues***

Our revenues are primarily derived from registrations for domain names in the *.com* and *.net* domain name registries. We also derive revenues from operating domain name registries and technical systems for several other gTLDs and one ccTLD, all of which are not significant in relation to our consolidated revenues. For domain names registered in the .*com* and .*net* registries, we receive a fee from registrars per annual registration that is determined pursuant to our agreements with ICANN. Individual customers, called registrants, contract directly with registrars or their resellers, and the registrars, who are our direct customers, in turn register the domain names with Verisign. Changes in revenues are driven largely by changes in the number of new domain name registrations and the renewal rate for existing registrations as well as the impact of new and prior price increases, to the extent permitted by ICANN and the Department of Commerce. New registrations and the renewal rate for existing registrations are impacted by continued growth in online advertising, e-commerce, and the number of internet users, as well as marketing activities carried out by us and our registrars. We also offer promotional incentive-based discount programs to registrars based upon market conditions and the business environment in which the registrars operate.

In November 2024, we renewed the *.com* Registry Agreement with ICANN, pursuant to which we will remain the sole registry operator for the *.com* registry through November 30, 2030. Under the .*com* Registry Agreement, we are permitted to increase the price of a *.com* domain name registration by up to 7% in each of the final four years of each six-year period. The current such six-year period began on October 26, 2024. We increased the annual registry-level wholesale fee for each new and renewal .*com* domain name registration from $9.59 to $10.26 effective September 1, 2024. On April 23, 2026, we announced that we will increase the annual registry-level wholesale fee for each new and renewal .*com* domain name registration from $10.26 to $10.97 effective November 1, 2026. Under the *.net* Registry Agreement, we are permitted to increase the price of *.net* 

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

domain name registrations by up to 10% each year during the term of our agreement with ICANN, through June 30, 2029. We increased the annual registry-level wholesale fee for each new and renewal *.net* domain name registration from $9.92 to $10.91 effective February 1, 2024. All fees paid to us for *.com* and *.net* registrations are in U.S. dollars.

A comparison of revenues is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **% Change** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Revenues | $428.9 | 7% | $402.3 |

---

The following table compares the *.com* and *.net* domain name registrations in the domain name base:

---

| | | | |
|:---|:---|:---|:---|
| | **March 31, 2026** | **% Change** | **March 31, 2025** |
| *.com* and *.net* domain name registrations in the domain name base | 176.1 million | 4% | 169.8 million |

---

Revenues increased during the three months ended March 31, 2026, as compared to the same period last year, primarily due to an increase in the domain name base as of March 31, 2026 compared to March 31, 2025 and the *.com* and *.net* price increases.

Demand for *.com* and *.net* domain names has been primarily driven by continued internet growth and marketing activities carried out by us and our registrars. However, the demand for .*com* and .*net* domain names may be limited by competitive pressure from other TLDs and alternatives for an online presence. Additionally, changes in internet practices, consumer behavior, and global economic conditions, as well as the motivation of existing domain name registrants managing their investment in domain names, such as for resale at increased prices or for revenue generation through website advertising, may impact demand for .*com* and .*net* domain names. Our domain name base increased during the three months ended March 31, 2026 compared to March 31, 2025, as the positive domain name base trends that began in 2025 continued into 2026 with higher new registrations and renewal rates. Growth in the domain name base has been positively impacted by continued registrar focus on customer acquisition and engagement with our marketing programs, as well as the evolution of AI tools used in content and website creation.

***Geographic revenues***

We generate revenues in the U.S.; Europe, the Middle East and Africa ("EMEA"); Australia, China, Japan, Singapore, and other Asia Pacific countries ("APAC"); and certain other countries, including Canada and Latin American countries.

The following table presents a comparison of our geographic revenues:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **% Change** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| U.S. | $283.4 | 7% | $266.1 |
| EMEA | 73.5 | 10% | 67.0 |
| APAC | 48.0 | 8% | 44.4 |
| Other | 24.0 | (3)% | 24.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $428.9 |  | $402.3 |

---

Revenues in the table above are attributed to the country of domicile and the respective regions in which our registrars are located; however, this may differ from the regions where the registrars operate or where registrants are located. Revenue growth for each region may be impacted by registrars reincorporating, relocating, or from acquisitions or changes in affiliations of resellers. Revenue growth for each region may also be impacted by registrars domiciled in one region, registering domain names in another region. Our revenue growth was generated from registrars based in the U.S., EMEA and APAC during the three months ended March 31, 2026, compared to the same period in 2025.

***Cost of revenues***

Cost of revenues consists primarily of salaries and employee benefits expenses for our personnel who manage the operational systems, depreciation expenses, operational costs associated with the delivery of our services, fees paid to ICANN, customer support and training, costs of facilities and computer equipment used in these activities, telecommunications expense and allocations of indirect costs such as corporate overhead.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

A comparison of cost of revenues is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **% Change** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Cost of revenues | $49.2 | (1)% | $49.4 |

---

Cost of revenues remained consistent during the three months ended March 31, 2026, compared to the same period last year.

***Research and development***

Research and development expenses consist primarily of costs related to research and development personnel, including salaries and other personnel-related expenses, consulting fees, facilities costs, computer and communications equipment, support services used in our service and technology development, and allocations of indirect costs such as corporate overhead.

A comparison of research and development expenses is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **% Change** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Research and development | $27.5 | 6% | $26.0 |

---

Research and development expenses increased slightly during the three months ended March 31, 2026, compared to the same period last year, due to a combination of individually insignificant factors.

***Selling, general and administrative***

Selling, general and administrative expenses consist primarily of salaries and other personnel-related expenses for our executive, administrative, legal, finance, information technology, human resources, sales, and marketing personnel, travel and related expenses, trade shows, costs of computer and communications equipment and support services, consulting and professional service fees, costs of marketing programs, costs of facilities, management information systems, support services, and certain tax and license fees, offset by allocations of indirect costs such as facilities and shared services expenses to other cost types.

A comparison of selling, general and administrative expenses is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **% Change** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Selling, general and administrative | $58.6 | 5% | $55.7 |

---

Selling, general and administrative expenses increased during the three months ended March 31, 2026, compared to the same period last year, primarily due to an increase in compensation and benefits expenses, including stock-based compensation expenses. Compensation and benefits expenses, including stock-based compensation expenses, increased by $2.8 million, primarily due to annual salary increases and an increase in the total projected achievement levels on certain performance-based RSU grants.

***Interest expense***

Interest expense decreased slightly during the three months ended March 31, 2026, compared to the same period last year, primarily due to the period of overlap between the issuance of $500.0 million of 5.25% senior unsecured notes due June 2032 ("2032 Notes") and repayment of $500.0 million aggregate principal amount of outstanding senior unsecured notes due April 2025 ("2025 Notes") in March 2025.

***Non-operating income, net***

Non-operating income decreased during the three months ended March 31, 2026, compared to the same period last year, primarily due to a decrease in interest income as a result of lower amounts invested in debt securities in the current period compared to the prior period and a decrease in interest rates on the Company's investments in debt securities.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

***Income tax expense***

The following table presents income tax expense and the effective tax rate:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Income tax expense | $64.9 | $59.1 |
| Effective tax rate | 23% | 23% |

---

The effective tax rate for each of the periods in the table above differed from the statutory federal rate of 21%, due to state income taxes and U.S. taxes on foreign earnings, net of foreign tax credits, partially offset by a lower foreign effective tax rate.

**Liquidity and Capital Resources**

The following table presents our principal sources of liquidity:

---

| | | |
|:---|:---|:---|
| | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| | **(In millions)** | **(In millions)** |
| Cash and cash equivalents | $476.7 | $307.9 |
| Marketable securities | 79.7 | 272.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $556.4 | $580.5 |

---

The marketable securities primarily consist of debt securities issued by the U.S. Treasury meeting the criteria of our investment policy, which is focused on the preservation of our capital through investment in investment grade securities. The cash equivalents consist of amounts invested in money market funds, time deposits and U.S. Treasury bills purchased with original maturities of three months or less. As of March 31, 2026, all of our debt securities have contractual maturities of less than one year. Our cash and cash equivalents are readily accessible. For additional information on our investment portfolio, see Note 2, "Financial Instruments," of our Notes to Condensed Consolidated Financial Statements in Part I, Item I of this Quarterly Report on Form 10-Q.

Effective July 24, 2025, the Board of Directors authorized the repurchase of common stock in the amount of $913.1 million, in addition to the $586.9 million that remained available for repurchases under the share repurchase authorization, for a total repurchase authorization of up to $1.50 billion under the program. During the three months ended March 31, 2026, we repurchased 0.9 million shares of common stock for an aggregate cost of $214.4 million. As of March 31, 2026, there was $862.8 million remaining available for future share repurchases under the share repurchase program.

In the three months ended March 31, 2026, we paid dividends of $74.2 million. On April 20, 2026, the Board of Directors declared a cash dividend of $0.81 per share of the Company's outstanding common stock to stockholders of record as of the close of business on May 19, 2026, payable on May 27, 2026. We intend to continue to pay a cash dividend on a quarterly basis, subject to market conditions and approval by the Board of Directors.

As of March 31, 2026, we had $500.0 million principal amount outstanding of the 2032 Notes, $750.0 million principal amount outstanding of 2.70% senior unsecured notes due 2031, and $550.0 million principal amount outstanding of 4.75% senior unsecured notes due 2027. As of March 31, 2026, we had no outstanding borrowings and $200.0 million in borrowing capacity under our credit facility which matures in 2028.

We believe existing cash, cash equivalents and marketable securities, and funds generated from operations, together with our ability to arrange for additional financing should be sufficient to meet our working capital, capital expenditure requirements, fund our quarterly dividend, and to service our debt for the next 12 months and beyond. We regularly assess our cash management approach and activities in view of our current and potential future needs. Our cash requirements have not changed materially since the 2025 Form 10-K.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

In summary, our cash flows for the three months ended March 31, 2026 and 2025 were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | **(In millions)** | **(In millions)** |
| Net cash provided by operating activities | $272.4 | $291.3 |
| Net cash provided by investing activities | 187.2 | 317.6 |
| Net cash used in financing activities | (291.1) | (239.9) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 0.3 | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase in cash, cash equivalents, and restricted cash | $168.8 | $368.7 |

---

*Cash flows from operating activities*

Our largest source of operating cash flows is cash collections from our customers. Our primary uses of cash from operating activities are for personnel-related expenditures and other general operating expenses, as well as payments related to taxes, interest and facilities.

Net cash provided by operating activities decreased during the three months ended March 31, 2026, compared to the same period last year, primarily due to increases in cash paid to employees and vendors and cash paid for income taxes, and a decrease in cash received from customers, partially offset by a decrease in cash paid for interest. Cash paid to employees and vendors increased primarily due to the timing of payments. Cash paid for income taxes increased primarily due to comparatively higher federal, state and non-US income tax payments. Cash received from customers decreased primarily due to timing of payments from certain large customers. Cash paid for interest decreased due to the payment of interest accrued on the 2025 Notes in March 2025, prior to their maturity date of April 1, 2025.

*Cash flows from investing activities*

The changes in cash flows from investing activities primarily relate to purchases, maturities and sales of marketable securities, and purchases of property and equipment.

Net cash provided by investing activities decreased during the three months ended March 31, 2026, compared to the same period last year, primarily due to a decrease in proceeds from maturities and sales of marketable securities, net of purchases of marketable securities.

*Cash flows from financing activities*

The changes in cash flows from financing activities primarily relate to proceeds from and repayment of borrowings, share repurchases, dividend payments, and proceeds from our employee stock purchase plan.

Net cash used in financing activities increased during the three months ended March 31, 2026, compared to the same period last year, primarily due to dividend payments to shareholders, partially offset by a decrease in share repurchases and the net impact of the redemption of our 2025 Notes and the issuance of our 2032 Notes in March 2025.

**ITEM 3. &nbsp;&nbsp;&nbsp;&nbsp;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

There have been no significant changes in our market risk exposures since December 31, 2025.

**ITEM 4.&nbsp;&nbsp;&nbsp;&nbsp;CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

Our management, with the participation of our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), evaluated the effectiveness of our disclosure controls and procedures. Based on this evaluation, as of March 31, 2026, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**Changes in Internal Control over Financial Reporting**

There was no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2026 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

**Inherent Limitations of Disclosure Controls and Internal Control over Financial Reporting**

Because of their inherent limitations, our disclosure controls and procedures and our internal control over financial reporting may not prevent material errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The effectiveness of our disclosure controls and procedures and our internal control over financial reporting is subject to risks, including that the controls may become inadequate because of changes in conditions or that the degree of compliance with our policies or procedures may deteriorate.

**PART II—OTHER INFORMATION**

**ITEM 1.&nbsp;&nbsp;&nbsp;&nbsp;LEGAL PROCEEDINGS**

As previously disclosed, Afilias Domains No. 3 Limited (now called Altanovo Domains Limited), a competitor and losing bidder in the .*web* auction, filed another Independent Review Process ("IRP") against ICANN pursuant to ICANN's bylaws, on July 14, 2023. In April 2026, post-hearing briefing was completed.

We are also involved in various investigations, claims and lawsuits arising in the normal conduct of our business, none of which, in our opinion, will have a material adverse effect on our financial condition, results of operations, or cash flows. We cannot assure you that we will prevail in any litigation. Regardless of the outcome, any litigation may require us to incur significant litigation expense and may result in significant diversion of management attention.

 **ITEM 1A.**&nbsp;&nbsp;&nbsp;&nbsp;**RISK FACTORS** 

*Our business, operating results, financial condition, reputation, cash flows or prospects can be materially adversely affected by a number of factors, including but not limited to those described in Part I, Item 1A of the 2025 Form 10-K under the heading "Risk Factors." In such case, the trading price of our common stock could decline and you could lose part or all of your investment. Additional risks and uncertainties not currently known to us or that we currently deem immaterial may also materially adversely affect our business, operating results, financial condition, reputation, cash flows and prospects. Actual results could differ materially from those projected in the forward-looking statements contained in this Form 10-Q as a result of the risk factors described in Part I, Item 1A of the 2025 Form 10-K and in other filings we make with the SEC. There have been no material changes to the Company's risk factors since the 2025 Form 10-K.*

**ITEM 2.&nbsp;&nbsp;&nbsp;&nbsp;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

The following table presents the share repurchase activity during the three months ended March 31, 2026:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Total Number**<br>**of Shares**<br>**Purchased** | **Average<br>Price Paid<br>per Share** | **Total Number**<br>**of Shares**<br>**Purchased as**<br>**Part of Publicly**<br>**Announced**<br>**Plans or**<br>**Programs (1)** | **Approximate**<br>**Dollar Value of**<br>**Shares That May**<br>**Yet Be Purchased**<br>**Under the Plans or**<br>**Programs (1) (2)** | **Approximate**<br>**Dollar Value of**<br>**Shares That May**<br>**Yet Be Purchased**<br>**Under the Plans or**<br>**Programs (1) (2)** |
| | **(Shares in thousands)** | **(Shares in thousands)** | **(Shares in thousands)** | **(Shares in thousands)** | **(Shares in thousands)** |
| January 1 - 31, 2026 | 232 | $247.77 | 232 | $1019.8 | million |
| February 1 - 28, 2026 | 335 | $221.54 | 335 | $945.5 | million |
| March 1 - 31, 2026 | 346 | $239.18 | 346 | $862.8 | million |
|  | 913 |  | 913 |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Effective July 24, 2025 the Board of Directors authorized the repurchase of common stock in the amount of $913.1 million, in addition to the $586.9 million that remained available for repurchases under the prior share repurchase authorization, for a total repurchase authorization of up to $1.50 billion under the program. The share repurchase program has no expiration date. Purchases made under the program can be effected through open market transactions, block purchases, accelerated share repurchase agreements or other negotiated transactions.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Amounts presented are exclusive of the excise tax on share repurchases.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION**

**Insider Trading Arrangements**

Our directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act.

On March 3, 2026, D. James Bidzos, the Company's Executive Chairman, President and Chief Executive Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 100,000 shares of Company common stock between June 2, 2026 and May 27, 2027, subject to certain conditions.

On March 3, 2026, Thomas Indelicarto, the Company's Executive Vice President, General Counsel and Secretary, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 12,000 shares of Company common stock between June 2, 2026 and May 24, 2027, subject to certain conditions.

There were no other directors or executive officers that adopted, terminated or modified plans or other arrangements during the quarter ended March 31, 2026.

**ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS**

As required under Item 6—Exhibits, the exhibits filed as part of this report are provided in this separate section. The exhibits included in this section are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Exhibit<br>Number** | **Exhibit Description** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|  |  | Form | Date | Number | Filed Herewith |
| 31.01 | <u>[Certification of Principal Executive Officer pursuant to Exchange Act Rule 13a-14(a).](vrsn-2026331x10qxex3101.htm)</u> |  |  |  | X |
| 31.02 | <u>[Certification of Principal Financial Officer pursuant to Exchange Act Rule 13a-14(a).](vrsn-2026331x10qxex3102.htm)</u> |  |  |  | X |
| 32.01 | <u>[Certification of Principal Executive Officer pursuant to Exchange Act Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the U.S. Code (18 U.S.C. 1350). \*](vrsn-2026331x10qxex3201.htm)</u> |  |  |  | X |
| 32.02 | <u>[Certification of Principal Financial Officer pursuant to Exchange Act Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the U.S. Code (18 U.S.C. 1350). \*](vrsn-2026331x10qxex3202.htm)</u> |  |  |  | X |
| 101 | Interactive Data File. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | X |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |  |  |  | X |

---

\* As contemplated by SEC Release No. 33-8212, these exhibits are furnished with this Quarterly Report on Form 10-Q and are not deemed filed with the SEC and are not incorporated by reference in any filing of VeriSign, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in such filings.

------

<u>[**Table of Contents**](#i8aa50e23264647138c7f66a501a45c42_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | VERISIGN, INC. |
| Date: April 23, 2026 | By: | /S/&nbsp;&nbsp;&nbsp;&nbsp;D. JAMES BIDZOS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; |
|  |  | **D. James Bidzos** |
|  |  | ***Chief Executive Officer*** |

---

---

| | | |
|:---|:---|:---|
| Date: April 23, 2026 | By: | /S/ JOHN D. CALYS  |
|  |  | **John D. Calys** |
|  |  | ***Chief Financial Officer*** |

---

## Exhibit 31.01

**EXHIBIT 31.01** 

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO** 

**EXCHANGE ACT RULE 13a-14(a)/15d-14(a)** 

**AS ADOPTED PURSUANT TO SECTION 302** 

**OF THE SARBANES-OXLEY ACT OF 2002** 

I, D. James Bidzos, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of VeriSign, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: April 23, 2026 | By: | /S/ D. JAMES BIDZOS |
|  |  | **D. James Bidzos** |
|  |  | ***Chief Executive Officer*** |

---

## Exhibit 31.02

**EXHIBIT 31.02** 

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO** 

**EXCHANGE ACT RULE 13a-14(a)/15d-14(a)** 

**AS ADOPTED PURSUANT TO SECTION 302** 

**OF THE SARBANES-OXLEY ACT OF 2002** 

I, John D. Calys, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of VeriSign, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: April 23, 2026 | By: | /S/ JOHN D. CALYS |
|  |  | **John D. Calys** |
|  |  | ***Chief Financial Officer*** |

---

## Exhibit 32.01

**EXHIBIT 32.01** 

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO** 

**18 U.S.C. SECTION 1350** 

**AS ADOPTED PURSUANT TO SECTION 906** 

**OF THE SARBANES-OXLEY ACT OF 2002** 

I, D. James Bidzos, Chief Executive Officer of VeriSign, Inc. (the "Company"), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 31, 2026, as filed with the Securities and Exchange Commission (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: April 23, 2026 | /S/ D. JAMES BIDZOS |
| | **D. James Bidzos** |
| | ***Chief Executive Officer*** |

---

## Exhibit 32.02

**EXHIBIT 32.02** 

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO** 

**18 U.S.C. SECTION 1350** 

**AS ADOPTED PURSUANT TO SECTION 906** 

**OF THE SARBANES-OXLEY ACT OF 2002** 

I, John D. Calys, Chief Financial Officer of VeriSign, Inc. (the "Company"), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 31, 2026, as filed with the Securities and Exchange Commission (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: April 23, 2026 | /S/ JOHN D. CALYS |
| | **John D. Calys** |
| | ***Chief Financial Officer*** |

---

<br>